Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2019-08-06 00:18 2019-08-01 USAT CANTALOUPE, INC. Hudson Executive Capital LP 10% owner Calculating & Accounting Machines (No Electronic Computers) BUY $6.93 1,000,252 $6,931,746 8,195,972 +13.9%
2019-08-06 03:15 2019-08-01 FSLY Fastly, Inc. Abdiel Capital Management, LLC 10% owner Services-Prepackaged Software BUY $19.53 120,863 $2,360,527 2,687,498 +4.7%
2019-08-06 00:45 2019-08-01 PBF PBF Energy Inc. Inversora Carso, S.A. de C.V. 10% owner, Other Petroleum Refining BUY $24.80 686,500 $17,024,445 15,073,681 +4.8%
2019-08-05 21:04 2019-08-01 F FORD MOTOR CO FORD WILLIAM CLAY JR Director, Officer - Exec. Chairman and Chairman Motor Vehicles & Passenger Car Bodies BUY $9.51 840,962 $7,995,783 1,100,617 +323.9%
2019-08-05 15:00 2019-08-02 MYL N/A COURY ROBERT J Director Other BUY $20.06 49,859 $1,000,012 947,194 +5.6%
2019-08-06 01:19 2019-08-01 BTU PEABODY ENERGY CORP ELLIOTT INTERNATIONAL, L.P. 10% owner Bituminous Coal & Lignite Surface Mining BUY $18.34 634,698 $11,642,202 19,787,764 +3.3%
2019-08-03 03:53 2006-10-31 AUSI AURA SYSTEMS INC Breslow Warren 10% owner Miscellaneous Electrical Machinery, Equipment & Supplies BUY $0.45 7,643,462 $3,428,093 7,478,611 +100.0%
2019-08-02 21:14 2019-05-08 FARM FARMER BROTHERS CO Levin Easterly Partners LLC 10% owner Miscellaneous Food Preparations & Kindred Products BUY $17.43 129,979 $2,265,196 2,533,128 +5.4%
2019-08-02 23:49 2019-08-02 ETRN N/A KARAM THOMAS F Director, Officer - Chairman and CEO Other BUY $16.39 100,000 $1,639,000 450,000 +28.6%
2019-08-03 00:02 2019-07-31 ABBV AbbVie Inc. AUSTIN ROXANNE S Director Pharmaceutical Preparations BUY $65.86 55,000 $3,622,091 117,114 +88.5%
2019-08-02 01:32 2019-08-01 ETRN N/A KARAM THOMAS F Director, Officer - Chairman and CEO Other BUY $16.11 100,000 $1,611,000 350,000 +40.0%
2019-08-02 00:11 2019-07-30 ATEX Anterix Inc. Owl Creek Asset Management, L.P. 10% owner Telephone Communications (No Radiotelephone) BUY $44.47 96,861 $4,307,215 3,297,631 +3.0%
2019-08-01 04:41 2019-07-29 FLLCU N/A Swipy Ltd 10% owner Other BUY $10.00 214,500 $2,145,000 1,652,000 +14.9%
2019-08-01 04:40 2019-07-29 FLLCU N/A Wong Ting Lun Director, Officer, 10% owner - Chief Executive Officer Other BUY $10.00 214,500 $2,145,000 1,652,000 +14.9%
2019-08-01 04:39 2019-07-29 FLLCU N/A Chong Jonathan Peng Fai Director, Officer, 10% owner - Chief Financial Officer Other BUY $10.00 214,500 $2,145,000 1,652,000 +14.9%
2019-08-01 04:37 2019-07-29 FLLCU N/A Toh Anderson Heng Hee Director, Officer, 10% owner - Chief Operating Officer Other BUY $10.00 214,500 $2,145,000 1,652,000 +14.9%
2019-08-01 00:00 2019-07-29 LVGO N/A Kinnevik AB (publ) 10% owner Other BUY $28.00 3,141,795 $87,970,260 12,653,927 +33.0%
2019-07-31 23:46 2019-07-29 ABBV AbbVie Inc. Gosebruch Henry O Officer - EVP, Chief Strategy Officer Pharmaceutical Preparations BUY $67.28 30,000 $2,018,385 75,763 +65.6%
2019-08-01 03:29 2019-07-29 LVGO N/A Taneja Hemant Director, 10% owner Other BUY $28.00 2,678,571 $74,999,988 2,678,571 +100.0%
2019-08-01 03:22 2019-07-29 LVGO N/A General Catalyst Group Management Holdings GP, LLC 10% owner Other BUY $28.00 2,678,571 $74,999,988 2,678,571 +100.0%
2019-07-31 17:34 2019-07-29 EFF N/A Saba Capital Management, L.P. 10% owner Other BUY $15.26 80,875 $1,234,427 1,126,163 +7.7%
2019-08-01 00:38 2019-07-29 CSTL CASTLE BIOSCIENCES INC Cook Joseph C. III Director, 10% owner Services-Medical Laboratories BUY $16.00 334,745 $5,355,920 208,053 +100.0%
2019-08-01 00:57 2019-07-29 CSTL CASTLE BIOSCIENCES INC MGC Venture Partners 2013 GP, LLC 10% owner Services-Medical Laboratories BUY $16.00 312,500 $5,000,000 134,700 +100.0%
2019-08-01 04:43 2019-07-29 CSTL CASTLE BIOSCIENCES INC Sofinnova HealthQuest Partners, L.P. 10% owner Services-Medical Laboratories BUY $16.00 62,500 $1,000,000 1,833,577 +3.5%
2019-08-01 00:04 2019-07-29 TRN TRINITY INDUSTRIES INC Boze Brandon B Director, 10% owner, Other Railroad Equipment BUY $19.26 658,796 $12,687,027 22,561,698 +3.0%
2019-08-01 01:43 2019-07-29 EGLE N/A Oaktree Capital Group Holdings GP, LLC 10% owner Other BUY $4.56 650,000 $2,963,025 28,794,085 +2.3%
2019-07-31 23:30 2019-07-30 VCNX VACCINEX, INC. FRIEDBERG ALBERT Director, 10% owner Pharmaceutical Preparations BUY $4.08 1,838,235 $7,499,999 6,619,012 +38.5%
2019-08-01 03:25 2019-07-29 LVGO N/A GC Venture LH Manager, LLC 10% owner Other BUY $28.00 2,678,571 $74,999,988 2,678,571 +100.0%
2019-08-01 01:48 2019-07-29 CSTL CASTLE BIOSCIENCES INC KABAKOFF DAVID S Director, 10% owner Services-Medical Laboratories BUY $16.00 62,500 $1,000,000 1,833,577 +3.5%
2019-07-30 23:54 2019-07-30 SBE-U ChargePoint Holdings, Inc. McNeill Scott K. Director, Officer, 10% owner - CEO & CFO Miscellaneous Transportation Equipment BUY $10.00 103,000 $1,030,000 103,000 +100.0%
2019-07-29 15:42 2019-07-26 N-A N/A STRS OHIO 10% owner Other BUY $15.00 93,724 $1,405,867 4,696,408 +2.0%
2019-07-29 16:14 2019-07-26 N-A N/A STRS OHIO 10% owner Other BUY $15.00 368,708 $5,530,618 17,758,137 +2.1%
2019-07-30 03:31 2019-07-25 EGLE N/A Oaktree Capital Group Holdings GP, LLC 10% owner Other BUY $4.76 1,000,000 $4,760,000 28,144,085 +3.7%
2019-07-30 00:18 2019-07-25 ATEX Anterix Inc. Owl Creek Asset Management, L.P. 10% owner Telephone Communications (No Radiotelephone) BUY $44.90 41,300 $1,854,341 3,200,770 +1.3%
2019-07-29 23:40 2019-07-25 SLDB Solid Biosciences Inc. PERCEPTIVE ADVISORS LLC Director, 10% owner Biological Products, (No Diagnostic Substances) BUY $4.65 2,822,581 $13,125,002 6,749,803 +71.9%
2019-07-27 02:09 2019-07-24 NGM N/A Svennilson Peter Director, 10% owner Other BUY $13.49 89,866 $1,212,427 15,903,671 +0.6%
2019-07-27 01:57 2019-07-24 NGM N/A COLUMN GROUP L P 10% owner Other BUY $13.49 89,866 $1,212,427 2,334,580 +4.0%
2019-07-26 18:48 2019-07-26 APD Air Products and Chemicals Inc. Ghasemi Seifi Officer - Chairman, Pres. and CEO Industrial Inorganic Chemicals BUY $227.16 20,000 $4,543,200 453,783 +4.6%
2019-07-27 02:24 2019-07-24 NGM N/A GOEDDEL DAVID V Director, 10% owner Other BUY $13.49 89,866 $1,212,427 16,093,671 +0.6%
2019-07-26 23:27 2019-07-24 THC TENET HEALTHCARE CORP GLENVIEW CAPITAL MANAGEMENT, LLC 10% owner Services-General Medical & Surgical Hospitals, NEC BUY $19.62 827,424 $16,231,659 18,717,654 +4.6%
2019-07-27 00:57 2019-07-26 CNX CNX Resources Corp LANIGAN BERNARD JR Director Crude Petroleum & Natural Gas BUY $6.39 200,000 $1,277,600 637,950 +45.7%
2019-07-25 19:42 2019-07-23 ESPR Esperion Therapeutics, Inc. BIOTECH TARGET N V 10% owner Pharmaceutical Preparations BUY $42.65 50,000 $2,132,565 3,572,964 +1.4%
2019-07-25 23:05 2019-07-23 NHF NEXPOINT DIVERSIFIED REAL ESTATE TRUST DONDERO JAMES D Officer, 10% owner - See Remarks Real Estate Investment Trusts BUY $18.85 546,286 $10,297,500 2,416,448 +29.2%
2019-07-26 00:38 2019-07-23 CCI CROWN CASTLE INC. MARTIN J LANDIS Director Real Estate Investment Trusts BUY $127.33 16,300 $2,075,461 4,100 +100.0%
2019-07-24 23:16 2019-07-22 MIRM Mirum Pharmaceuticals, Inc. O'Donnell Niall Director Pharmaceutical Preparations BUY $15.00 300,000 $4,500,000 1,921,118 +18.5%
2019-07-24 23:53 2019-07-22 MIRM Mirum Pharmaceuticals, Inc. Chang Carmen 10% owner Pharmaceutical Preparations BUY $15.00 450,000 $6,750,000 4,186,243 +12.0%
2019-07-24 23:51 2019-07-22 MIRM Mirum Pharmaceuticals, Inc. New Enterprise Associates 16, L.P. 10% owner Pharmaceutical Preparations BUY $15.00 450,000 $6,750,000 4,186,243 +12.0%
2019-07-24 17:50 2019-07-24 N-A Crescent Capital BDC, Inc. Texas County & District Retirement System 10% owner Other BUY $19.79 461,872 $9,141,369 4,261,636 +12.2%
2019-07-24 23:54 2019-07-22 MIRM Mirum Pharmaceuticals, Inc. Makhzoumi Mohamad 10% owner Pharmaceutical Preparations BUY $15.00 450,000 $6,750,000 4,186,243 +12.0%
2019-07-25 00:00 2019-06-16 MDCL Medicine Man Technologies Inc. Dye Justin Director, 10% owner Services-Management Consulting Services BUY $2.00 3,500,000 $7,000,000 5,000,000 +233.3%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.